Table 1.
Sociodemographic and clinical characteristics of depressed patients by treatment group.
| Baseline Variable | All | All | Bupropion/Escitalopram | Escitalopram/Placebo | Venlafaxine/Mirtazapine | |||
|---|---|---|---|---|---|---|---|---|
| N=102 | % | N | % | N | % | N | % | |
|
| ||||||||
| Gender | ||||||||
| Female | 74 | 72.5 | 27 | 75.0 | 22 | 75.9 | 25 | 67.6 |
|
|
||||||||
| Male | 28 | 27.5 | 9 | 25.0 | 7 | 24.1 | 12 | 32.4 |
|
| ||||||||
| Race | ||||||||
| White | 73 | 71.6 | 28 | 77.8 | 18 | 62.1 | 27 | 73.0 |
|
|
||||||||
| Black | 19 | 18.6 | 6 | 16.7 | 6 | 20.7 | 7 | 18.9 |
|
| ||||||||
| Other | 10 | 9.8 | 2 | 5.6 | 5 | 17.2 | 3 | 8.1 |
|
| ||||||||
| Ethnicity | ||||||||
| Hispanic | 21 | 20.6 | 7 | 19.4 | 5 | 17.2 | 9 | 24.3 |
|
| ||||||||
| Employed | 46 | 45.1 | 16 | 44.4 | 8 | 27.6 | 22 | 59.5 |
|
| ||||||||
| NSAID User | 68 | 66.7 | 25 | 69.4 | 22 | 75.9 | 21 | 56.8 |
|
| ||||||||
| Mean | STD | Mean | STD | Mean | STD | Mean | STD | |
|
| ||||||||
| Age (yrs) | 46.42 | 10.7 | 48.11 | 10.3 | 49.38 | 10.2 | 42.46 | 10.5 |
|
| ||||||||
| BMI (Kg/m2) | 33.11 | 9.0 | 33.73 | 6.9 | 33.10 | 11.6 | 32.52 | 8.8 |
|
| ||||||||
| Education (yrs) | 13.72 | 2.8 | 13.44 | 2.6 | 14.41 | 3.6 | 13.43 | 2.2 |
|
| ||||||||
| Income | 2429.68 | 2351.6 | 2302.63 | 2214.6 | 2934.00 | 3205.0 | 2171.54 | 1636.3 |
|
| ||||||||
| HRS-D | 23.71 | 4.8 | 23.14 | 4.1 | 23.86 | 5.5 | 24.14 | 4.8 |
|
| ||||||||
| IDS-C | 37.75 | 9.0 | 36.19 | 8.5 | 37.69 | 9.5 | 39.32 | 8.9 |
|
| ||||||||
| QIDS-C | 15.75 | 3.7 | 14.86 | 3.7 | 16.14 | 3.5 | 16.30 | 3.7 |
|
| ||||||||
| QIDS-SR | 14.90 | 4.1 | 13.86 | 4.7 | 15.17 | 3.5 | 15.70 | 3.9 |
|
| ||||||||
| Number GMCs | 2.08 | 1.3 | 1.92 | 1.5 | 2.14 | 1.4 | 2.19 | 1.2 |